Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intuitive Surgical

484.44
+7.661.61%
Post-market: 484.440.00000.00%19:59 EDT
Volume:4.24M
Turnover:2.05B
Market Cap:172.78B
PE:75.46
High:492.28
Open:482.69
Low:476.57
Close:476.78
Loading ...

Company Profile

Company Name:
Intuitive Surgical
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
15638
Office Location:
1020 Kifer Road,Sunnyvale,California,United States
Zip Code:
94086-5304
Fax:
408 523 1390
Introduction:
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Directors

Name
Position
Gary S. Guthart
Director and Chief Executive Officer
Craig H. Barratt
Chair of the Board
David J. Rosa
President and Director
Amal M. Johnson
Director
Amy L. Ladd
Director
Jami Dover Nachtsheim
Director
Joseph C. Beery
Director
Keith R. Leonard, Jr.
Director
Lewis Chew
Director
Mark J. Rubash
Director
Monica P. Reed
Director
Sreelakshmi Kolli
Director

Shareholders

Name
Position
Gary S. Guthart
Director and Chief Executive Officer
Gary H. Loeb
Senior Vice President, General Counsel and Chief Compliance Officer
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Head of Business Technology
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
Bob DeSantis
Executive Vice President and Chief Strategy and Corporate Operations Officer
Brian E. Miller
Executive Vice President and Chief Digital Officer
David J. Rosa
President and Director
Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Marshall L. Mohr
Executive Vice President, Global Business Services
Myriam J. Curet
Executive Vice President and Chief Medical Officer